← Eichor
Study identifier: NCT06080659 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Network-based biOmarker Discovery of Neurodegenerative Diseases Using Multimodal Connectivity

Condition: Alzheimer Disease, Early Onset · Parkinson Disease  ·  Sponsor: Rennes University Hospital

PhaseNA
Planned participants120
Who can joinAll sexes, 50 Years to 80 Years
Healthy volunteersYes

About this study

The aim of the NODAL clinical trial is to demonstrate the feasibility of new, low-cost, non-invasive biomarkers of neurodegenerative pathologies as early Alzheimer and Parkinson, based on the estimation of the multimodal connectome.

This description comes directly from the study's public registry record.

Talk to the study team

marie-laure gervais, Phd  ·  299282555  ·  marie-laure.gervais@chu-rennes.fr

Pierre-Yves JONIN, PhD  ·  299284321  ·  pierreyves.jonin@chu-rennes.fr

Always discuss trial participation with your own doctor first.

Locations (1)

CHU RennesRennes, FranceRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06080659